title: Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.
abstract: A total of 234 clinical isolates of Aeromonas, primarily A. hydrophila, were collected for the present study. Most were isolates from blood. By the agar dilution method, more than 90% of the Aeromonas strains were found to be susceptible to moxalactam, ceftazidime, cefepime, aztreonam, imipenem, amikacin, and fluoroquinolones, but they were more resistant to tetracycline, trimethoprim-sulfamethoxazole, some extended-spectrum cephalosporins, and aminoglycosides than strains from the United States and Australia.
authors.affiliation: Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China.
authors.forename: W C
authors.initials: WC
authors.lastname: Ko
authors.forename: K W
authors.initials: KW
authors.lastname: Yu
authors.forename: C Y
authors.initials: CY
authors.lastname: Liu
authors.forename: C T
authors.initials: CT
authors.lastname: Huang
authors.forename: H S
authors.initials: HS
authors.lastname: Leu
authors.forename: Y C
authors.initials: YC
authors.lastname: Chuang
mesh_terms: D000333:Aeromonas / Q000187:drug effects* / Q000235:genetics; D016980:Aeromonas hydrophila / Q000187:drug effects; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology; D004352:Drug Resistance, Microbial / Q000235:genetics*; D024841:Fluoroquinolones; D008826:Microbial Sensitivity Tests; D013624:Taiwan
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D024841:Fluoroquinolones